Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Enovix
ENVX
$929M
| $1.65M | ﹤0.01% |
150,674
-1,662
| -1% | -$23.8K |
|
1952
ProPetro Holding
PUMP
$1.34B
| $1.65M | ﹤0.01% |
155,437
+21,160
| +16% | +$210K |
|
1953
White Mountains Insurance
WTM
$5.3B
| $1.65M | ﹤0.01% |
1,104
+23
| +2% | +$35.3K |
|
1954
iShares US Consumer Discretionary ETF
IYC
$1.21B
| $1.65M | ﹤0.01% |
+24,587
| New | +$1.74M |
|
1955
Cogent Communications
CCOI
$546M
| $1.64M | ﹤0.01% |
26,515
-16,753
| -39% | -$1.1M |
|
1956
Winnebago Industries
WGO
$885M
| $1.64M | ﹤0.01% |
27,558
+6
| +0% | +$389 |
|
1957
Elastic
ESTC
$7.27B
| $1.64M | ﹤0.01% |
20,153
+904
| +5% | +$61.6K |
|
1958
Ascendis Pharma A/S
ASND
$16.4B
| $1.64M | ﹤0.01% |
17,482
+16,874
| +2,775% | +$1.58M |
|
1959
Marqeta
MQ
$1.74B
| $1.64M | ﹤0.01% |
68,432
-6,445
| -9% | -$146K |
|
1960
O-I Glass
OI
$1.09B
| $1.63M | ﹤0.01% |
97,262
+6,649
| +7% | +$134K |
|
|
INST
1961
DELISTED
Instructure Holdings, Inc.
INST
| $1.62M | ﹤0.01% |
63,956
+17,873
| +39% | +$463K |
|
1962
Carpenter Technology
CRS
$27.7B
| $1.62M | ﹤0.01% |
24,148
-1,098
| -4% | -$66.6K |
|
1963
EPR Properties
EPR
$4.7B
| $1.62M | ﹤0.01% |
39,010
-10,742
| -22% | -$473K |
|
1964
Independent Bank Corp
IBCP
$855M
| $1.62M | ﹤0.01% |
88,307
-4,700
| -5% | -$89.5K |
|
|
DAWN
1965
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.62M | ﹤0.01% |
131,882
-12,521
| -9% | -$163K |
|
|
PDCO
1966
DELISTED
Patterson Companies, Inc.
PDCO
| $1.62M | ﹤0.01% |
54,513
-10,707
| -16% | -$340K |
|
|
NVO
1967
Novo Nordisk
NVO
$203B
| $1.61M | ﹤0.01% |
17,694
-9,842
| -36% | -$867K |
|
1968
Washington Trust Bancorp
WASH
$745M
| $1.61M | ﹤0.01% |
61,091
-1,869
| -3% | -$53.4K |
|
1969
Triple Flag Precious Metals
TFPM
$6.61B
| $1.61M | ﹤0.01% |
123,003
+907
| +0.7% | +$12.2K |
|
1970
Biomea Fusion
BMEA
$90.6M
| $1.6M | ﹤0.01% |
116,621
+49,485
| +74% | +$892K |
|
1971
Aclaris Therapeutics
ACRS
$851M
| $1.6M | ﹤0.01% |
234,150
+148,761
| +174% | +$1.27M |
|
1972
Privia Health
PRVA
$2.77B
| $1.6M | ﹤0.01% |
69,545
+13,656
| +24% | +$347K |
|
1973
Banco Bradesco
BBD
$37.1B
| $1.6M | ﹤0.01% |
560,318
-204,232
| -27% | -$646K |
|
1974
Green Brick Partners
GRBK
$3.07B
| $1.6M | ﹤0.01% |
38,430
-15,235
| -28% | -$761K |
|
1975
HSBC
HSBC
$352B
| $1.59M | ﹤0.01% |
40,271
+64
| +0.2% | +$2.52K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.